252 related articles for article (PubMed ID: 19549924)
1. Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch.
Elimova E; Kisilevsky R; Ancsin JB
FASEB J; 2009 Oct; 23(10):3436-48. PubMed ID: 19549924
[TBL] [Abstract][Full Text] [Related]
2. Amyloidogenesis recapitulated in cell culture: a peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy.
Elimova E; Kisilevsky R; Szarek WA; Ancsin JB
FASEB J; 2004 Nov; 18(14):1749-51. PubMed ID: 15345688
[TBL] [Abstract][Full Text] [Related]
3. Acute-phase serum amyloid A: perspectives on its physiological and pathological roles.
Kisilevsky R; Manley PN
Amyloid; 2012 Mar; 19(1):5-14. PubMed ID: 22320226
[TBL] [Abstract][Full Text] [Related]
4. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
Baltz ML; Rowe IF; Caspi D; Turnell WG; Pepys MB
Clin Exp Immunol; 1986 Dec; 66(3):701-8. PubMed ID: 3105937
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function.
Kisilevsky R; Subrahmanyan L
Lab Invest; 1992 Jun; 66(6):778-85. PubMed ID: 1602745
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation.
Noborn F; Ancsin JB; Ubhayasekera W; Kisilevsky R; Li JP
J Biol Chem; 2012 Jul; 287(30):25669-77. PubMed ID: 22654109
[TBL] [Abstract][Full Text] [Related]
7. Effect of serum amyloid A, HDL-apolipoprotein, on endothelial cell proliferation. Implication of an enigmatic protein to atherosclerosis.
Shainkin-Kestenbaum R; Zimlichman S; Lis M; Lidor C; Pomerantz M; Knyszynski A; Preciado-Patt L; Fridkin M
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):79-84. PubMed ID: 9575344
[TBL] [Abstract][Full Text] [Related]
8. The role of fibronectin in the development of experimental amyloidosis. Evidence of immunohistochemical codistribution and binding property with serum amyloid protein A.
Kawahara E; Shiroo M; Nakanishi I; Migita S
Am J Pathol; 1989 Jun; 134(6):1305-14. PubMed ID: 2757120
[TBL] [Abstract][Full Text] [Related]
9. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model.
Magy N; Benson MD; Liepnieks JJ; Kluve-Beckerman B
Amyloid; 2007 Mar; 14(1):51-63. PubMed ID: 17453625
[TBL] [Abstract][Full Text] [Related]
10. Syrian and Armenian hamsters differ in serum amyloid A gene expression. Identification of novel Syrian hamster serum amyloid A subtypes.
de Beer MC; de Beer FC; Beach CM; Gonnerman WA; Carreras I; Sipe JD
J Immunol; 1993 Jun; 150(12):5361-70. PubMed ID: 8515064
[TBL] [Abstract][Full Text] [Related]
11. The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis.
Ancsin JB; Kisilevsky R
J Biol Chem; 1999 Mar; 274(11):7172-81. PubMed ID: 10066777
[TBL] [Abstract][Full Text] [Related]
12. Generation and use of site-specific antibodies to serum amyloid A for probing amyloid A development.
Miura K; Ju ST; Cohen AS; Shirahama T
J Immunol; 1990 Jan; 144(2):610-3. PubMed ID: 2295803
[TBL] [Abstract][Full Text] [Related]
13. Acute-phase-HDL remodeling by heparan sulfate generates a novel lipoprotein with exceptional cholesterol efflux activity from macrophages.
Tam SP; Kisilevsky R; Ancsin JB
PLoS One; 2008; 3(12):e3867. PubMed ID: 19057652
[TBL] [Abstract][Full Text] [Related]
14. Heparin interactions with apoA1 and SAA in inflammation-associated HDL.
Digre A; Nan J; Frank M; Li JP
Biochem Biophys Res Commun; 2016 May; 474(2):309-314. PubMed ID: 27105909
[TBL] [Abstract][Full Text] [Related]
15. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
[TBL] [Abstract][Full Text] [Related]
16. Identification of regions responsible for heparin-induced amyloidogenesis of human serum amyloid A using its fragment peptides.
Egashira M; Takase H; Yamamoto I; Tanaka M; Saito H
Arch Biochem Biophys; 2011 Jul; 511(1-2):101-6. PubMed ID: 21569756
[TBL] [Abstract][Full Text] [Related]
17. Relation between serum amyloid A truncated peptides and their suprastructure chirality.
Rubin N; Perugia E; Wolf SG; Klein E; Fridkin M; Addadi L
J Am Chem Soc; 2010 Mar; 132(12):4242-8. PubMed ID: 20218685
[TBL] [Abstract][Full Text] [Related]
18. From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature.
Wang L; Lashuel HA; Colón W
Amyloid; 2005 Sep; 12(3):139-48. PubMed ID: 16194868
[TBL] [Abstract][Full Text] [Related]
19. Novel glycosaminoglycan precursors as anti-amyloid agents part II.
Kisilevsky R; Szarek WA
J Mol Neurosci; 2002; 19(1-2):45-50. PubMed ID: 12212792
[TBL] [Abstract][Full Text] [Related]
20. AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product.
Westermark GT; Sletten K; Grubb A; Westermark P
Am J Pathol; 1990 Aug; 137(2):377-83. PubMed ID: 2386201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]